1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co XNYS: LLY

Eli Lilly Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
1020.84 -86.28 (-7.79%)
63.65% Gain from 52W Low
7.7M
XNYS Volume
High volume+loss today

XNYS 05 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Eli Lilly is scheduled for today, for the purpose of Eli Lilly and Co Fourth Quarter Earnings Result for 2025 See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Expensive Valuation
30.0 / 100
Momentum Score
Technically Neutral
54.2 / 100
Expensive Performer These stocks are strong in quality but with mid-range technicals. Their valuations are expensive View Similar Embed DVM
Analyst Price Target
1,177
1Yr Price target upside is 15%
27 analysts

10

S

9

W

2

O

2

T

SWOT Analysis

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..